retatrutide phase 2 results 2024 2025 The Effect of on Kidney Parameters in Participants With Type Diabetes Mellitus and/or Obesity Retatrutide study sees significant weight

Pre-loaded syringes are particularly problematic: plastic syringe barrels are permeable to gases and can introduce trace contamination

All use subcutaneous injection

Higher protein intake (1.0-1.2 g/kg for older adults and 1.2-1.6 g/kg for those engaging in resistance training) may help preserve lean muscle mass

Future research will likely concentrate on discovering biomarkers and patient traits that may predict treatment response, facilitating more tailored therapy selection

Studies show that GLP-1 receptor agonists, drugs that mimic GLP-1, have been shown to help people with type 2 diabetes (T2D) and obesity lose weight and control their blood sugar [2]

An experienced family medicine physician or NP who regularly manages obesity can prescribe retatrutide just as appropriately as an endocrinologist." Not every prescriber will be comfortable writing for an investigational compound accessed through compounding